- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04947748
Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous
June 24, 2021 updated by: North Estonia Medical Centre
Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Edgar Lipping, MD
- Phone Number: 6171520
- Email: edgar.lipping@regionaalhaigla.ee
Study Contact Backup
- Name: Sten Saar, MD, PhD
- Phone Number: 6171520
- Email: sten.saar@regionaalhaigla.ee
Study Locations
-
-
-
Tallin, Estonia
- Recruiting
- North Estonia Medical Centre
-
Contact:
- Edgar Lipping, MD
- Phone Number: 6171520
- Email: edgar.lipping@regionaalhaigla.ee
-
Contact:
- Sten Saar, MD, PhD
- Phone Number: 6171520
- Email: sten.saar@regionaalhaigla.ee
-
Principal Investigator:
- Edgar Lipping, MD
-
Sub-Investigator:
- Sten Saar, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients diagnosed with acute appendicitis and are candidates for laparoscopic appendectomy.
Exclusion Criteria:
Patients with compromised immune system (HIV, diabetes), ongoing or completed radio-chemotherapy in past 5 years, prosthetic heart valve, vascular prosthesis, pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 24 hour intravenous antibacterial therapy
S.Augmentin 1,2g x 3 i/v
|
Mode of administration of antibacterial treatment
|
Experimental: 24 hour oral antibacterial therapy
T.Augmentin 1g x 3 p/o
|
Mode of administration of antibacterial treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Infectious complications
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Edgar Lipping, MD, North Estonia Medical Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Anticipated)
December 31, 2021
Study Completion (Anticipated)
December 31, 2021
Study Registration Dates
First Submitted
June 24, 2021
First Submitted That Met QC Criteria
June 24, 2021
First Posted (Actual)
July 1, 2021
Study Record Updates
Last Update Posted (Actual)
July 1, 2021
Last Update Submitted That Met QC Criteria
June 24, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Infections
- Peritoneal Diseases
- Wounds and Injuries
- Disease Attributes
- Gastrointestinal Diseases
- Gastroenteritis
- Intestinal Diseases
- Cecal Diseases
- Intraabdominal Infections
- Rupture
- Acute Disease
- Appendicitis
- Peritonitis
- Anti-Infective Agents
- Anti-Bacterial Agents
Other Study ID Numbers
- 1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Appendicitis
-
Pirogov Russian National Research Medical UniversityCompletedAcute Appendicitis | Acute Appendicitis With Rupture | Acute Appendicitis Without Peritonitis | Acute Appendicitis With PeritonitisRussian Federation
-
HJ23Hospital Universitari Joan XXIII de Tarragona.Not yet recruitingAcute Appendicitis | Appendicitis Perforated | Appendicitis Suppurative
-
Turku University HospitalOulu University Hospital; Kuopio University Hospital; Seinajoki Central Hospital and other collaboratorsNot yet recruitingUncomplicated Acute AppendicitisFinland
-
Hospital Universitario Virgen de la ArrixacaUnknownUncomplicated Acute AppendicitisSpain
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Tanta UniversityCompletedDiagnosis of Acute Appendicitis in ChildrenEgypt
-
A.O. Ospedale Papa Giovanni XXIIIUnknownAcute Appendicitis Without PeritonitisItaly
-
Nigde Omer Halisdemir UniversityCompletedAcute Appendicitis | Acute Appendicitis With RuptureTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedMedical Emergencies | Acute Appendicitis Without PeritonitisTurkey
-
King Abdulaziz UniversityCompletedAppendicitis | Acute Appendicitis | Pathology | Appendicitis (Diagnosis)Saudi Arabia
Clinical Trials on Oral versus intravenous administration of antibacterial treatment
-
Centre Hospitalier Universitaire, AmiensRecruitingFluid Therapy | Pharmacodynamics | Fluid Responsiveness | Fluid Challenge | Intravenous FluidsFrance
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasCompletedAmyotrophic Lateral SclerosisSpain
-
Chang Gung Memorial HospitalRecruitingNeutropenia | Pediatric Cancer | G-CSF | Lenograstim | FilgrastimTaiwan
-
Medicines for Malaria VentureRichmond Pharmacology LimitedCompleted
-
Hospital Infantil de Mexico Federico GomezHospital Juarez de Mexico; Instituto Nacional de PediatriaCompletedChemotherapy-Induced Febrile Neutropenia
-
Hookipa Biotech GmbHRecruitingHPV-Related Squamous Cell CarcinomaUnited States, Spain, Netherlands
-
Stichting Achmea Slachtoffer en SamenlevingCompletedRSD (Reflex Sympathetic Dystrophy) | Algodystrophy | CRPS Type INetherlands
-
University of OxfordColumbia University; ETH Zurich; Jomo Kenyatta University of Agriculture and... and other collaboratorsRecruitingPregnancy | Lactation | Iron Absorption | Iron Requirements | InfancyKenya
-
Yonsei UniversityCompletedType 2 Diabetes | Non-alcoholic Fatty Liver DiseaseKorea, Republic of
-
Milton S. Hershey Medical CenterCompleted